chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had severe fatigue, fever, and chills x 48 hours after shot. I did get slightly better a few days after shot, but am now 3 weeks out and am still not back to normal. I have gotten worse again for last 2 weeks. I have seen multiple doctors and am still undergoing testing. I have extreme fatigue and shortness of breath. So far I have been told bronchitis, pneumonitis, and possible reactive airway disease. I am now being treated for new adult onset asthma and have been tested for multiple autoimmune disorders that are still pending. I was also told possible myocarditis if all of this checks out and may need further testing and pulmonary specialist. It may all be unrelated and coincidental, however, I have not been well since this shot and one of my doctors told me to report this in case it is linked. I just want to get back to my normal.
On 03/09/2023 I was experiencing headache, congestion, sore throat. After reaching out to my doctor I was diagnosed with Covid-19. I was prescribed Paxlovid and symptoms lasted about 1 week. After doing a check up a week later I was then diagnosed with a sinus infection. The sinus infection lasted about 1 week.
States she experienced swelling in arm, pain in 3 discs in her back, unable to walk, stomach pain, possible kidney damage. Hospitalized for 1 week then went back to hospital the following day after discharge.
More vaginal bleeding - it starts before the  normal cycle and goes past the normal cycle - It's spotting. It's brown or red - it fluctuates in color back and forth. It is like post surgical bleeding (almost like post partum bleeding). Usually about a week before my period and at least a week to two weeks after. I go without any spotting only 5 days or so in the month. That has been going on for at least 6 months. I got started on Metformin to see if that would help with my trying to get pregnant but nothing has been given to me with the spotting/bleeding issue. This last cycle it went to day 15 of this one.
Information has been received from a published article. This literature case was initially reported on 29-Mar-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received RECOMBIVAX HB, manufacturer, batch number, route and site not reported, on unreported date. This report concerns patient #18 of 32, a 39 year old male. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination in three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second dose of vaccine. One patient had recurrent uveitis after both the second and third doses. Patient outcome had not been reported. A 39 year old male on an unspecified date was vaccinated with the third dose of RECOMBIVAX HB (lot number, route and site not reported). There was no concomitant medications. One day after vaccination, the patient developed uveitis. At the time of the report, the patient's outcome was not reported. The authors stated the RECOMBIVAX HB may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB (WAES # 1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02342, WAES # 1004USA02344 to WAES 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
Fever, body aches, chills, sweats, vomiting, nausea, headache within 8 hours after receiving vaccine
Patient came to ED with leg pain, cough, abdominal pain, progressive SOB, and dysuria.  She was admitted with Covid and a UTI.
Patient had had Bexxero and Menactra vaccines on Monday, April 5 at her primary care MD office.  The student administering the vaccine believed the computer would not let him proceede if it were not advised, so he gave the Covid 19 vaccine despite the patient answering that she had recieved another vaccine within the llast 14 days.  The patient had no reaction, mother aware. I called the pediatrician to make aware. I spoke with my medical advisor, who states none of the vaccines are live dose vaccines and reccomended the second dose of the covid vaccine be held for 1 week. Second dose scheduled as such.
I have a patient who received the MODERNA vaccine on 08/13/21 and was severely allergic to it. The symptoms started 30 minutes to 1 hour after the vaccination which include fever, intense localized painful swelling, and malaise.  Symptoms continued for 4 days until she decided to go to the hospital and was admitted for 3 days.
Repeat visit to ER for pain and redness, right upper arm. On 6/24/04 at 9AM. Dx. LUE Erythema? Reaction to TD vs Cellulitis. Treatment: antibiotic, NSAIDS, PMO 48 hours
She's been feeling cold (her body is feeling cold); Cough; Feels like her throat is inflamed; Has not been able to go to work; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiry date was not reported, age at vaccination: 51-year-old), via an unspecified route of administration on 07Jul2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Jul2021, the patient had been feeling cold (her body is feeling cold). She has a cough and she feels like her throat is inflamed. She has not been able to go to work and now her company/employer is asking her for some papers from her doctor. She was wondering if she needs to book an appointment for that. So, she was referred her doctor. The outcome of events was unknown.  Information on the lot/batch number has been requested.
On Sunday morning, April 18, as I was walking home, I experienced an intense pain in my chest, abdomen, back and all my teeth. This did not subside until I returned home and sat down.
Active tonsil stone infection at time of vaccination, which worsened after recieving Gardasil9, showing signs of reactivation of pathogen/virus such as streptococcus & Epstein Barr virus within first 2 weeks.   In the following 4-52 weeks after recieving Gardasil9, the following chronic illness symptoms developed:   Excema, psoriasis, worsened tonsil stones, increased full body cystic acne breakouts, chronic fatigue (incapacitating, sleeping 16+ hrs a day), memory loss, headaches/migraines, blurred vision, mood swings (no previous history of mental illness or instability), loss of focus & "brain fog",  general inflammation, joint pain, muscle pain,  back pain, dark circles under eyes, yellowing skin.   During weeks 52-104 all symptoms steadily worsened to the point of incapacitation due to fatigue.  During this time patient saw other doctors and specialists, who prescribed more antibiotics which exacerbated symptoms.  It was not until 4 years after recieving Gardasil9 that the patient found considerable links to the vaccine. Patient has since undergone rigorous detoxification with positive results, indicating that viral reactivation did indeed occur and was allowed to proliferate and spread to organs like the liver.  Overall, the administering doctor should have never have given a vaccine to someone displaying an active infection via tonsil stones, or without any screening to determine if patient is at risk for adverse effects.   Patient insists this vaccine caused or brought about long term, or chronic illness/disease that were previously nonexistent. Sufficient screening could have prevented unnecessary suffering and risk to publuc health
Associate was seen in the Emergency room  10/22/2021 , w/ complaints of chest pain and shortness of breath Symptoms started approximately 2 hours  after vaccine
Injection site local reaction. Raised, warm red area 6 1/2 cm x 3 1/2 cm.
HAV, VARIVAX, & H1N1 vaccines admin. at approx 1:15pm. States started breaking out in hives on her chest at approx. 145pm with itching on her chest & arms. Between 230p-245p started feeling chest tightness & at 3p started facing tightness & itching in her throat.
menstrual cycle  unusually heavy /bleeding has Not Stopped as of today's date; menstrual cycle... unusually heavy, severe cramps; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: FC3181), via an unspecified route of administration in Arm Left on 03Sep2021 at 10:00 (at 49 years) as single dose for covid-19 immunisation.  Patient had known allergies to Penicillin and Codeine. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included semaglutide (RYBELSUS) taken for an unspecified indication, start and stop date were not reported. Previously 13Aug2021 at 10:00 am (at 49 years) the patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: FC3180), via an unspecified route of administration in Arm Right for covid-19 immunisation.On 06Sep2021 (within 3 days of second shot, as reported) the patient started menstrual cycle, unusually heavy, severe cramps and bleeding has not stopped as of 22Oct2021. This was debilitating . There was no way she could hold a job with these effects. No treatment given and patient not recovered from the events.No follow-up attempts are needed. No further information is expected
Received covid vaccine at county health department on 12/27/21. C/o sudden onset dyspnea at home just PTA to ER. Less than 5 minute drive to ER. Arrived at ER at 11:27. Loss consciousness, followed by cardiac arrest, shortly after arrive to ER parking lot. ROSC achieved, but coded two more times in ER. Transferred to higher level of care facility. Per family, is declared braindead and is being removed from life support on 12/30/21.
Patient developed SOB but reported good O2Sats. Instructed on going to ER if worsening symptoms. Patient eventually expired on 1/22/21
4 yo m seen in Health Dept for vaccines. Mother reports no allergies & no problem with previous vaccines - vaccines given & pt sent to lobby to await school - blue form. Mother reported rash after 10 min - pt had petechaie rash on neck & face - no other location. Mother instructed to take child to pediatrician also to remain in clinic for 30 min for observation - pt with no resp distress. Mother did not stay she left.
FELL FOR NO REASON; CHEST IS SO TIGHT ALL THE TIME; RESPIRATORY ARREST; DIFFICULTY TAKING DEEP BREATHS; This spontaneous report received from a patient concerned a 67 year old of unspecified sex, unknown race, and ethnic origin. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had severe immune IgG (Immunoglobulin G). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-MAR-2021, the patient experienced a reaction within 1 hour of receiving the vaccination. Within 40 minutes, the patient went into respiratory arrest. The patient was finally able to breathe but with a lot of difficulty. The patient had an appointment with her Physician the next day (14-MAR-2021) and since then she had been on 3 Liter oxygen 24/7. When the patient did not  realize what was going on, a couple of times the patient fell for no reason and that was because was not getting enough oxygen in her system. The patient still had difficulty taking deep breaths on the day of reporting, and her chest felt so tight all the time. The patient knew she needed the booster but did not know which one and where. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from respiratory arrest, chest is so tight all the time, and difficulty taking deep breaths, and the outcome of fell for no reason was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210830722-Covid-19 vaccine ad26.cov2.s -Respiratory arrest , Difficulty taking deep breaths. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Approximately 10 days post vax, pt developed 7-8 bumps underneath skin around shot area. It was noted that the rash was very red and small bumps. Pt was treated with cold compresses on the area.
Muscle, pain,tired, weak, headache, shivering, diarrhea, vomiting, stomach pain.
The patient started crying at 11:30 am and continued to cry until 4:15 pm. The patient screamed whenever she moved her legs. The patient was fine after 4:15.
Menstrual cycle has been  super irregular and happening every other week and cramps have worsened and flow is super heavy.
Heart Rate went really fast; Felt odd, like whole body was vibrating; Lightheadedness; Tired; Caller has not received second dose of the Pfizer Covid Vaccine; This is a spontaneous report from a contactable consumer (patient) to Pfizer sponsored program support. A 55-years old female received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, (Lot Number: EP7533 expiry date was not reported) dose 1 via an unspecified route of administration at arm Left on 02Apr2021 (at the age of 55-years-old) as a single dose for covid-19 immunisation. Medical history included ongoing thyroiditis (she was diagnosed in her 20's), ongoing fibromyalgia (she was diagnosed about 5 years ago), ongoing asthma (she has had this condition on and off for 5-6 years). The patient's concomitant medications were not reported. caller mentioned that she had the tDAP vaccine last year in June or July and had no adverse events. States she has never had an adverse reaction to a vaccine On 02Apr2021 light-headedness and tired, on 03Apr2021 the patient experienced heart rate went really fast, felt odd, like whole body was vibrating, caller has not received second dose of the pfizer covid vaccine (circumstance or information capable of leading to medication error). Caller stated she never reported her symptoms when they occurred, she only told her doctor about them. Caller Stated that within minutes of getting the vaccine she had light-headedness. She went home, was tired, and went to sleep, Stated the next day she felt like her body was vibrating, said that is when her heart rate started, stated it lasted probably more than a week, sometimes it would be beating so fast it would wake her up in the middle of the night. Caller was afraid that she will feel the same way with the second dose of the Pfizer Covid Vaccine. The outcome of the event circumstance or information capable of leading to medication error was unknown and other outcome of the events was recovered on an unspecified date Apr2021.  Information on batch/lot numbers are available. Further information has been requested.
On 10/7/04 observed rash over body "round spots, raised somewhat", non pruritic,very irritable, awkened earlier than normal, fever present (?101) on 10/7 only, irritability lasted for 3 days, rash gone today,it had gradually faded, treated with Tylenol.
I started with a headache. It lasted for about five days. I didn't have body aches but I had joint aches. My ankle, knee, wrist and fingers - all of my joints hurt but they didn't ache. I had gastro-intestinal issues. They all started about the end of day 2 and beginning of day three after the vaccine. I had stomach discomfort. I eventually had diarrhea on day three or four. On the first day after the vaccine, I felt extreme vaccine and that lasted about 7 days. It was the kind of exhaustion as when you're first pregnant but times 10. I couldn't sleep well and I was so, so tired. I got acupuncture for my joint pain. Everything pretty much dissipated by day 8. Except, I do still have some pain in my right ankle - in the Achilles tendon area. That started right away and I have had acupuncture for that a few times. Note: I have MTHFR blood clotting disease - I specifically have A1278C. It can cause blood clotting but the vaccine did not cause this issue in me.
Continual migraine, taken to hospital for stroke like symptoms, dehydration, sensitivity to light, muscle pain and fatigue, brain fog.
08:50AM Upon standing to leave pt stated she was lightheaded & dizzy.  Instructed to sit. BP: 126/80, SO2 RA 96%, HR:80x' Pt stated she was nervous when getting the vaccine.   09:05AM Still "feeling off, blurred vision." 09:10AM SO2 RA: 100%, HR: 82  Drinking water.  Denies SOB 09:30AM feeling better.  Encouraged not to drive.  A friend here that will take pt. home.  Pt advised to F/U with her PCP 10:03AM Pt discharged
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 12-NOV-2010, the patient received improperly stored VARIVAX dose 2, from lot # 66685/0280Z, expiry date 12-FEB-2012 (dose, vaccination site, route unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
A physician reported that a 70-year-old female received an injection TD absorbed on 28-JAN-1999 and subsequently reported that she developed an injection site reaction characterized by a 3-incg area of redness and soreness. Four days post-immunization, the patient reported that the redness had "moved down" her arm and that the injection site was warm and " 1 5 inches raised".
I was supposed to get my period the day of the vaccine. I am now 6 days late.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 20Apr2021 at 10:30(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included acne and attention deficit hyperactive disorder (ADHD). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and spironolactone (SPIRONOLACTON) all from unknown date for unknown indication and unknown if ongoing. On 20Apr2021 at 10:30, the patient experienced delayed period. The Patient reported that she was supposed to get her period on the day of the vaccination, but was 6 days late. The Patient had tested negative for pregnancy tests. There had been no changes in diet, exercise, weight, stress this month and  the patient had always exercised, managed weight and stress that month, and also her periods had always been extremely regular and had never missed a period or been late (with the exception of 2 pregnancies). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested positive for COVID-19. The clinical outcome of the event, delayed period was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
This literature report (initial receipt 10-Apr-2012) concerns a 76-year-old female patient. The patient had no clinical or laboratory evidence suggestive of precipitating conditions. In 2010/2011 the patient received H1N1 (manufacturer is unknown). 4 weeks after receiving H1N1 the patient developed her first symptom of Guillain-Barre syndrome (GBS). Sensory symptoms included paresthesias and numbness in bilateral toes progressing to both legs, and then to bilateral fingers and loss of balance. Motor symptoms included loss of dexterity and dysphagia and no weakness. A neurological examination revealed generalized weakness (graded to 4/5), decreased pinprick, joint position and vibration in both lower extremities, unsteady upon stance and gait, deep tendon reflexes 1+ in both upper extremities and absent patellar and ankle reflexes. The patient's cerebrospinal fluid (CSF) protein was 78mg/dl which was considered elevated. 7 weeks after receiving H1N1 electrodiagnostic findings revealed sural sparing, prolonged distal latencies and absent or abnormal F responses which was highly suggestive of acute inflammatory demyelinating polyradiculoneuropathy. Clinical history, neurological exam, imaging studies, and serological and CSF markers excluded other etiologies of acute neuropathy such as vasculitis, vitamin deficiency, toxic neuropathy and porphyria. Treatment included intravenous immunoglobulin (IVIG) 0.4kg/day for 5 days. One week after receiving treatment with IVIG the patient showed improved sensations and slow improvement of weakness and dysphagia. The patient resumed their baseline level of activities by 6 months. Reporters comment: Clinical history, serological studies and CSF findings did not point to any other precipitating conditions except for the H1N1-influenza vaccination. The Brighton Collaborative Working Group established criteria for GBS in association with vaccine. The patient did not have one of the diagnostic certainty criteria recommended by the working group however the working group recognised that their case definitions might not include some rare and atypical clinical variants of GBS. A relationship between the vaccine and GBS was not necessarily established.